Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 80NSSC21M0057 | Other Grant/Funding Number | NASA |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Aeronautics and Space Administration (NASA) | FED |
Not provided
Not provided
Not provided
Not provided
The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
The rehabilitation device guides users to perform sinusoidal head rotations, matched to a metronome, about the yaw, pitch, and roll axes (60 sec epochs, 5 minutes per axis, 15 min total). The assessment for each axis consists of the number of completed epochs with each epoch requiring head rotations of a different amplitude. Subjects are instructed to begin with an 'easy' amplitude (i.e. small) and increase or decrease amplitude depending on the subject's perception of motion sickness - which is input from 0 (absent motion sick) to 11 (vomit) using a handheld controller. Video-oculography captures eye and head velocity as well as tracks the number of blinks and saccades, metrics that can indicate worsening nausea.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traditional Vestibular Physical Therapy (VPT) JHU | Active Comparator | Subjects that have had their eighth cranial nerve resected will receive traditional vestibular rehabilitation exercises at Johns Hopkins University (JHU) site. |
|
| SWAN VPT JHU | Experimental | Subjects that have had their eighth cranial nerve resected will receive the automated vestibular rehabilitation method |
|
| SWAN Motion Sick Dayton | Experimental | Healthy control subjects that meet similar similar physical characteristics of astronauts will receive the automated vestibular rehabilitation method post motion sickness. |
|
| Traditional Motion Sick Dayton | No Intervention | Typically, the suggestion for treating motion sickness once it has started is to avoid motion. Therefore, healthy control subjects that meet similar similar physical characteristics of astronauts will not receive any post motion sickness treatment. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Traditional Therapy | Behavioral | Exercises that teaches subjects to move their heads while viewing still or moving targets. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Motion sickness intensity as assessed by subjective rating | Subjective rating of motion sickness intensity from 0 to 10. Zero denotes absent motion sickness while 10 denote vomiting. | Daily for up to 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Vestibulo-Ocular Reflex (VOR) gain as measured by video-oculography | Ratio of eye velocity to head velocity that varies from 0 to 1.2. Normal scores are greater than 0.8. | Daily for up to 4 weeks |
| Change in Number of blinks as measured by video-oculography |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Michael Schubert, PhD | Contact | 4108427403 | mschube1@jhmi.edu | |
| Matthew Stewart, MD PhD | Contact | 4109553492 | cstewa16@jhmi.edu |
| Name | Affiliation | Role |
|---|---|---|
| Matthew Stewart, MD PhD | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins University | Recruiting | Baltimore | Maryland | 21287 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36075099 | Background | Todd CJ, Schubert MC, Rinaudo CN, Migliaccio AA. Unidirectional Vertical Vestibuloocular Reflex Adaptation in Humans Using 1D and 2D Scenes. Otol Neurotol. 2022 Oct 1;43(9):e1039-e1044. doi: 10.1097/MAO.0000000000003684. Epub 2022 Sep 9. |
| Label | URL |
|---|---|
| Patent for the rehabilitation device | View source |
Not provided
Currently, we have no plan to share data with other researchers
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015837 | Vestibular Diseases |
| D009464 | Neuroma, Acoustic |
| D018489 | Space Motion Sickness |
| D009041 | Motion Sickness |
| ID | Term |
|---|---|
| D007759 | Labyrinth Diseases |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D009442 | Neurilemmoma |
Not provided
Not provided
At each site, one group will receive the control and the second group will receive the experimental treatment (novel rehab device).
Not provided
Not provided
Not provided
Not provided
|
| SWAN | Device | The SWAN device uses video-oculography to monitor head motion while guiding participants to move their head in yaw, pitch, roll planes for 15 minutes. Feedback is provided regarding frequency and plane of head rotation |
|
|
Increase blinking is correlated with worse motion sickness. |
| Daily for up to 4 weeks |
| Change in Heart rate as measured by a monitor worn over the forearm | Heart rate in beats per minute will be measured using a monitor worn over the forearm. | Daily for up to 4 weeks |
| Change in Timed Up and Go Plus | Time measured in seconds for a subject to stand up, step over an obstacle then walk 3M before turning around and sitting down. | Daily for up to 4 weeks |
| Change in Foam Stance - Eyes Open | Time in seconds to stand on foam with eyes open. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling. | Daily for up to 4 weeks |
| Change in Foam Stance - Eyes Closed | Time in seconds to stand on foam with eyes closed. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling. | Daily for up to 4 weeks |
| Change in Foam Stance - Eyes Open with head motion | Time to seconds to stand on foam with eyes open while moving head up and down. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling. | Daily for up to 4 weeks |
| Change in Foam Stance - Eyes Closed with head motion | Time in seconds to stand on foam with eyes closed while moving head up and down. Inability to stand for less than 20 seconds is associated with 3x greater risk for falling. | Daily for up to 4 weeks |
| Change in Gait speed | Velocity to walk 6m within a 10m marked distance, measured in meters/second. Normative data exists based on decade of age. | Daily for up to 4 weeks |
| Change in Gait endurance | Distance walked in 2 minutes, measure in meters. | Daily for up to 4 weeks |
| Change in Vertical and torsional alignment nulling test (VAN and TAN) | Vertical alignment nulling and torsional alignment nulling ask subjects to adjust lines to there perceived horizontal. Measured in degrees. | Daily for up to 4 weeks |
| Change in Rod and Frame Test | Subjects adjust a virtual line to their perceived vertical, measured in degrees. | Daily for up to 4 weeks |
| Change in Rod and Disk Test | Subjects adjust a virtual line to their perceived vertical, measured in degrees. | Daily for up to 4 weeks |
| Change in Subjective Visual Vertical | Subjects adjust a virtual line to their perceived vertical, measured in degrees. | Daily for up to 4 weeks |
| Change in Daily Activity as assessed by an activity monitor | Subjects wear an activity monitor on their wrist Data includes daily distance walked . | Daily for up to 4 weeks |
| Naval Medical Research Unit | Enrolling by invitation | Dayton | Ohio | 45433 | United States |
| Patent for the integrated video-oculography and rehabilitation device | View source |
| D018358 |
| Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D009463 | Neuroma |
| D018317 | Nerve Sheath Neoplasms |
| D009380 | Neoplasms, Nerve Tissue |
| D003390 | Cranial Nerve Neoplasms |
| D009423 | Nervous System Neoplasms |
| D009371 | Neoplasms by Site |
| D010524 | Peripheral Nervous System Neoplasms |
| D000160 | Vestibulocochlear Nerve Diseases |
| D012181 | Retrocochlear Diseases |
| D010039 | Otorhinolaryngologic Neoplasms |
| D003389 | Cranial Nerve Diseases |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |